Current Status of the Application of Immune Checkpoint Inhibitors in Liver Transplantation for Hepatocellular Carcinoma

1. Abstract
Immune Checkpoint Inhibitors (ICIs) are one of the effective treat- ments for patients with advanced hepatocellular carcinoma and effectively prolong their survival. However, it is still controversial whether ICIs can be used in liver transplantation for hepatocellular carcinoma.